Formulation Development White Papers & Articles

  1. Navigating Nitrosamine Impurities In Pharmaceutical Drug Development 3/3/2026

    Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.

  2. How The Accelerator™ Drug Development Model Enhances eNPV 2/25/2026

    Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.

  3. How To Choose The Appropriate Filter Material For Every Sample 2/24/2026

    Membrane compatibility plays a crucial role in reliable sample filtration. Knowing how different filter materials interact helps prevent common workflow issues and supports efficient filtration.

  4. A CDMO Is The Nexus Between Green Chemistry And Commercialization 2/24/2026

    Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.

  5. Why Reshoring Is An Essential Strategy For ADC Supply Chain Security 2/24/2026

    Biotechs reshoring their supply chains to Western regions to mitigate risk and improve reliability require experienced partners to effectively manage these complex transitions.

  6. A Patented Process For Intermediates Useful For Upadacitinib 2/18/2026

    Discover how innovative and safer synthetic strategies can streamline the manufacture of Upadacitinib while addressing the complexity and safety challenges inherent in its key intermediates.

  7. Corticosteroids And Hormonal Therapies — History, Use, And Future Outlook 2/18/2026

    Explore how evolving science, expanding global demand, and next-generation innovations are reshaping the future of corticosteroid and hormonal therapies — and what this transformation means for the years ahead.

  8. Redefining OSD Development Through Foresight And Innovation 2/12/2026

    From early formulation challenges to scale-up and commercial readiness, proactive planning and integrated capabilities help teams anticipate risks, accelerate decision-making, and maintain momentum across development.

  9. Right From The Start: Smarter Developability For Stronger Formulations 2/4/2026

    Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.

  10. NGS In GMP Manufacturing: Reducing Risk, Increasing Return 1/29/2026

    Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.